<DOC>
	<DOCNO>NCT00412932</DOCNO>
	<brief_summary>This 14 week study examine ability olmesartan medoxomil lower blood pressure patient 65 year age old high blood pressure . The medication test approved FDA treatment high blood pressure .</brief_summary>
	<brief_title>An Examination Blood Pressure Lowering Ability Safety Olmesartan Medoxomil Elderly Patients With Hypertension</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Olmesartan</mesh_term>
	<mesh_term>Olmesartan Medoxomil</mesh_term>
	<mesh_term>Hydrochlorothiazide</mesh_term>
	<mesh_term>Angiotensin-Converting Enzyme Inhibitors</mesh_term>
	<criteria>1 . Males Females great 65 year age 2 . Patients mean seat systolic blood pressure ( MSSBP ) great equal 150 mmHg less 200 mm Hg mean seat diastolic blood pressure ( MSDBP ) less equal 109 mmHg follow 23 week single blind placebo runin period . 3 . The difference MSSBP visit 2 3 visit 3 3x must less equal 10 mmHg . 4 . Patients mean daytime ( 8am4pm ) systolic blood pressure ( SBP ) great equal 140 mmHg less equal 199 mmHg mean daytime diastolic blood pressure ( DBP ) less equal 109 mmHg measure ambulatory blood pressure monitoring device ( ABPM ) follow placebo runin period . 1 . History stroke transient ischemic attack ( TIA ) within last one year . 2 . History myocardial infarction , angina , coronary angioplasty , coronary artery bypass graft , heart failure within past 6 month . 3 . Severe hypertension ( diastolic blood pressure great 115 mmHg systolic blood pressure great equal 200 mmHg ) . 4 . Patients secondary hypertension etiology , renal disease , pheochromocytoma Cushing 's syndrome . 5 . Type I diabetes Type II diabetic stable treatment great equal 4 week plasma glucose great 160 mg/dl . 6 . Evidence symptomatic resting bradycardia , congestive heart failure , hemodynamically significant cardiac valvular disease . 7 . Presence heart block great first degree sinoatrial block , WolffParkinsonWhite Syndrome , Sick Sinus Syndrome , accessory bypass tract , atrial fibrillation , atrial flutter arrhythmia require medication . 8 . Serum Creatinine great 1.7 mg/dl , abnormal laboratory value deem clinically significant investigator .</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2009</verification_date>
	<keyword>Hypertension</keyword>
	<keyword>Angiotensin Receptor Blocker</keyword>
	<keyword>Calcium Channel Blocker</keyword>
	<keyword>Angiotensin Converting Enzyme Inhibitor</keyword>
	<keyword>Hydrochlorothiazide</keyword>
	<keyword>Stage I II Hypertension</keyword>
</DOC>